Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Physiological and pathological roles of protein kinase A in the heart
Protein kinase A (PKA) is a central regulator of cardiac performance and morphology.
Myocardial PKA activation is induced by a variety of hormones, neurotransmitters, and stress …
Myocardial PKA activation is induced by a variety of hormones, neurotransmitters, and stress …
3D bioprinting for cardiovascular regeneration and pharmacology
Cardiovascular disease (CVD) is a major cause of morbidity and mortality worldwide.
Compared to traditional therapeutic strategies, three-dimensional (3D) bioprinting is one of …
Compared to traditional therapeutic strategies, three-dimensional (3D) bioprinting is one of …
Large and small animal models of heart failure with reduced ejection fraction
Heart failure (HF) describes a heterogenous complex spectrum of pathological conditions
that results in structural and functional remodeling leading to subsequent impairment of …
that results in structural and functional remodeling leading to subsequent impairment of …
SIRT1 protects the heart from ER stress-induced cell death through eIF2α deacetylation
A Prola, J Pires Da Silva, A Guilbert, L Lecru… - Cell Death & …, 2017 - nature.com
Over the past decade, endoplasmic reticulum (ER) stress has emerged as an important
mechanism involved in the pathogenesis of cardiovascular diseases including heart failure …
mechanism involved in the pathogenesis of cardiovascular diseases including heart failure …
[HTML][HTML] Alpha-ketoglutarate ameliorates pressure overload-induced chronic cardiac dysfunction in mice
D An, Q Zeng, P Zhang, Z Ma, H Zhang, Z Liu, J Li… - Redox Biology, 2021 - Elsevier
Increasing evidence indicates the involvement of myocardial oxidative injury and
mitochondrial dysfunction in the pathophysiology of heart failure (HF). Alpha-ketoglutarate …
mitochondrial dysfunction in the pathophysiology of heart failure (HF). Alpha-ketoglutarate …
Pharmacologic ATF6 activation confers global protection in widespread disease models by reprograming cellular proteostasis
EA Blackwood, K Azizi, DJ Thuerauf… - Nature …, 2019 - nature.com
Pharmacologic activation of stress-responsive signaling pathways provides a promising
approach for ameliorating imbalances in proteostasis associated with diverse diseases …
approach for ameliorating imbalances in proteostasis associated with diverse diseases …
Ferroptosis contributes to catecholamine-induced cardiotoxicity and pathological remodeling
Y Chen, X Guo, Y Zeng, X Mo, S Hong, H He… - Free Radical Biology …, 2023 - Elsevier
High levels of circulating catecholamines cause cardiac injury, pathological remodeling, and
heart failure, but the underlying mechanisms remain elusive. Here we provide both in vitro …
heart failure, but the underlying mechanisms remain elusive. Here we provide both in vitro …
Enhanced mitochondria-SR tethering triggers adaptive cardiac muscle remodeling
Z Nichtová, C Fernandez-Sanz… - Circulation …, 2023 - ahajournals.org
Background: Cardiac contractile function requires high energy from mitochondria, and Ca2+
from the sarcoplasmic reticulum (SR). Via local Ca2+ transfer at close mitochondria-SR …
from the sarcoplasmic reticulum (SR). Via local Ca2+ transfer at close mitochondria-SR …
Nuclear ATR lysine-tyrosylation protects against heart failure by activating DNA damage response
R Zhao, K Cai, JJ Yang, Q Zhou, W Cao, J **ang… - Cell Reports, 2023 - cell.com
Dysregulated amino acid increases the risk for heart failure (HF) via unclear mechanisms.
Here, we find that increased plasma tyrosine and phenylalanine levels are associated with …
Here, we find that increased plasma tyrosine and phenylalanine levels are associated with …
Comprehensive mechanism, novel markers and multidisciplinary treatment of severe acute pancreatitis-associated cardiac injury–a narrative review
YL Luo, ZX Li, P Ge, HY Guo, L Li… - Journal of …, 2021 - Taylor & Francis
Acute pancreatitis (AP) is one of the common acute abdominal inflammatory diseases in
clinic with acute onset and rapid progress. About 20% of the patients will eventually develop …
clinic with acute onset and rapid progress. About 20% of the patients will eventually develop …